Certified by Founder Lodge
Bristol Myers Squibb
United States - Lawrence Township, NJ
INVESTOR
1 Disclosed Funding Rounds $105,000,000
14 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experien
Company | Date | Round | Raised |
---|---|---|---|
Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
Mediar Therapeutics | March, 15 ,2023 | Unknown | $105,000,000 |
Cellares | August, 24 ,2023 | Series C | $255,000,000 |
Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
AstronauTx | October, 09 ,2023 | Series A | $58,462,000 |
Pathios Therapeutics | April, 19 ,2024 | Series B | $25,000,000 |
Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
Envisagenics | June, 06 ,2024 | Series B | |
Asher Biotherapeutics | April, 17 ,2024 | Series C | $55,000,000 |
Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
Pathios Therapeutics | April, 19 ,2024 | Series B | $25,000,000 |
Envisagenics | June, 06 ,2024 | Series B | |
Outpace Bio | August, 02 ,2024 | Series B | $144,000,000 |
Be Biopharma | October, 23 ,2024 | Unknown | $82,000,000 |